nodes	percent_of_prediction	percent_of_DWPC	metapath
Gefitinib—STK10—blood plasma—Creutzfeldt-Jakob disease	0.0387	0.0426	CbGeAlD
Gefitinib—SBK1—spinal cord—Creutzfeldt-Jakob disease	0.0331	0.0365	CbGeAlD
Gefitinib—SBK1—cerebellum—Creutzfeldt-Jakob disease	0.0263	0.029	CbGeAlD
Gefitinib—CSNK1E—Circadian rhythm pathway—NPAS2—Creutzfeldt-Jakob disease	0.0245	0.265	CbGpPWpGaD
Gefitinib—SBK1—brain—Creutzfeldt-Jakob disease	0.0213	0.0235	CbGeAlD
Gefitinib—HIPK4—brain—Creutzfeldt-Jakob disease	0.0211	0.0232	CbGeAlD
Gefitinib—EPHA6—central nervous system—Creutzfeldt-Jakob disease	0.021	0.0231	CbGeAlD
Gefitinib—IRAK4—lymphoid tissue—Creutzfeldt-Jakob disease	0.0199	0.0219	CbGeAlD
Gefitinib—CYP2C19—blood plasma—Creutzfeldt-Jakob disease	0.0198	0.0218	CbGeAlD
Gefitinib—MAP2K5—brainstem—Creutzfeldt-Jakob disease	0.0196	0.0216	CbGeAlD
Gefitinib—ERBB3—lymphoid tissue—Creutzfeldt-Jakob disease	0.0195	0.0215	CbGeAlD
Gefitinib—MAP3K19—central nervous system—Creutzfeldt-Jakob disease	0.0191	0.021	CbGeAlD
Gefitinib—CHEK2—brain—Creutzfeldt-Jakob disease	0.0186	0.0205	CbGeAlD
Gefitinib—MKNK2—lymphoid tissue—Creutzfeldt-Jakob disease	0.0185	0.0204	CbGeAlD
Gefitinib—CSNK1E—spinal cord—Creutzfeldt-Jakob disease	0.0183	0.0202	CbGeAlD
Gefitinib—MKNK1—lymphoid tissue—Creutzfeldt-Jakob disease	0.0183	0.0201	CbGeAlD
Gefitinib—IRAK4—spinal cord—Creutzfeldt-Jakob disease	0.018	0.0199	CbGeAlD
Gefitinib—ERBB3—spinal cord—Creutzfeldt-Jakob disease	0.0177	0.0195	CbGeAlD
Gefitinib—MKNK2—spinal cord—Creutzfeldt-Jakob disease	0.0168	0.0185	CbGeAlD
Gefitinib—EPHA6—brain—Creutzfeldt-Jakob disease	0.0167	0.0184	CbGeAlD
Gefitinib—MKNK1—spinal cord—Creutzfeldt-Jakob disease	0.0166	0.0183	CbGeAlD
Gefitinib—CYP3A5—blood plasma—Creutzfeldt-Jakob disease	0.0156	0.0172	CbGeAlD
Gefitinib—CYP2C9—blood plasma—Creutzfeldt-Jakob disease	0.0154	0.0169	CbGeAlD
Gefitinib—MAP3K19—brain—Creutzfeldt-Jakob disease	0.0152	0.0167	CbGeAlD
Gefitinib—EGFR—cerebellum—Creutzfeldt-Jakob disease	0.0151	0.0166	CbGeAlD
Gefitinib—STK10—lymphoid tissue—Creutzfeldt-Jakob disease	0.0151	0.0166	CbGeAlD
Gefitinib—CSNK1E—central nervous system—Creutzfeldt-Jakob disease	0.0148	0.0164	CbGeAlD
Gefitinib—IRAK4—central nervous system—Creutzfeldt-Jakob disease	0.0146	0.0161	CbGeAlD
Gefitinib—CSNK1E—cerebellum—Creutzfeldt-Jakob disease	0.0145	0.016	CbGeAlD
Gefitinib—ERBB3—central nervous system—Creutzfeldt-Jakob disease	0.0143	0.0158	CbGeAlD
Gefitinib—IRAK4—cerebellum—Creutzfeldt-Jakob disease	0.0143	0.0157	CbGeAlD
Gefitinib—ERBB3—cerebellum—Creutzfeldt-Jakob disease	0.014	0.0154	CbGeAlD
Gefitinib—MKNK2—central nervous system—Creutzfeldt-Jakob disease	0.0136	0.015	CbGeAlD
Gefitinib—MKNK1—central nervous system—Creutzfeldt-Jakob disease	0.0134	0.0148	CbGeAlD
Gefitinib—IRAK1—cerebellum—Creutzfeldt-Jakob disease	0.0133	0.0147	CbGeAlD
Gefitinib—MKNK2—cerebellum—Creutzfeldt-Jakob disease	0.0133	0.0147	CbGeAlD
Gefitinib—MKNK1—cerebellum—Creutzfeldt-Jakob disease	0.0131	0.0145	CbGeAlD
Gefitinib—EGFR—brain—Creutzfeldt-Jakob disease	0.0123	0.0135	CbGeAlD
Gefitinib—MAP2K5—spinal cord—Creutzfeldt-Jakob disease	0.0122	0.0134	CbGeAlD
Gefitinib—CSNK1E—brain—Creutzfeldt-Jakob disease	0.0118	0.013	CbGeAlD
Gefitinib—CYP3A4—blood plasma—Creutzfeldt-Jakob disease	0.0117	0.0129	CbGeAlD
Gefitinib—IRAK4—brain—Creutzfeldt-Jakob disease	0.0116	0.0128	CbGeAlD
Gefitinib—CYP2D6—blood plasma—Creutzfeldt-Jakob disease	0.0115	0.0127	CbGeAlD
Gefitinib—ERBB3—brain—Creutzfeldt-Jakob disease	0.0114	0.0125	CbGeAlD
Gefitinib—STK10—central nervous system—Creutzfeldt-Jakob disease	0.0111	0.0122	CbGeAlD
Gefitinib—STK10—cerebellum—Creutzfeldt-Jakob disease	0.0108	0.0119	CbGeAlD
Gefitinib—MKNK2—brain—Creutzfeldt-Jakob disease	0.0108	0.0119	CbGeAlD
Gefitinib—IRAK1—brain—Creutzfeldt-Jakob disease	0.0108	0.0119	CbGeAlD
Gefitinib—MKNK1—brain—Creutzfeldt-Jakob disease	0.0107	0.0118	CbGeAlD
Gefitinib—ORM1—spinal cord—Creutzfeldt-Jakob disease	0.0099	0.0109	CbGeAlD
Gefitinib—MAP2K5—central nervous system—Creutzfeldt-Jakob disease	0.00989	0.0109	CbGeAlD
Gefitinib—MAP2K5—cerebellum—Creutzfeldt-Jakob disease	0.00967	0.0107	CbGeAlD
Gefitinib—CSNK1E—Circadian Clock—NPAS2—Creutzfeldt-Jakob disease	0.00912	0.0986	CbGpPWpGaD
Gefitinib—STK10—brain—Creutzfeldt-Jakob disease	0.00879	0.00969	CbGeAlD
Gefitinib—ABCB1—blood plasma—Creutzfeldt-Jakob disease	0.00829	0.00913	CbGeAlD
Gefitinib—ORM1—central nervous system—Creutzfeldt-Jakob disease	0.00803	0.00885	CbGeAlD
Gefitinib—MAP2K5—brain—Creutzfeldt-Jakob disease	0.00785	0.00865	CbGeAlD
Gefitinib—CYP2D6—brainstem—Creutzfeldt-Jakob disease	0.00654	0.00721	CbGeAlD
Gefitinib—LOC400927-CSNK1E—Circadian rythm related genes—NPAS2—Creutzfeldt-Jakob disease	0.00616	0.0666	CbGpPWpGaD
Gefitinib—ABCG2—spinal cord—Creutzfeldt-Jakob disease	0.00593	0.00654	CbGeAlD
Gefitinib—ALB—brain—Creutzfeldt-Jakob disease	0.00559	0.00616	CbGeAlD
Gefitinib—ABCG2—cerebellum—Creutzfeldt-Jakob disease	0.0047	0.00518	CbGeAlD
Gefitinib—CYP1A1—central nervous system—Creutzfeldt-Jakob disease	0.00457	0.00503	CbGeAlD
Gefitinib—ABCG2—brain—Creutzfeldt-Jakob disease	0.00382	0.00421	CbGeAlD
Gefitinib—CSNK1E—FoxO family signaling—YWHAZ—Creutzfeldt-Jakob disease	0.00381	0.0413	CbGpPWpGaD
Gefitinib—CYP1A1—brain—Creutzfeldt-Jakob disease	0.00363	0.004	CbGeAlD
Gefitinib—CYP3A4—central nervous system—Creutzfeldt-Jakob disease	0.00335	0.00369	CbGeAlD
Gefitinib—CYP2D6—central nervous system—Creutzfeldt-Jakob disease	0.0033	0.00363	CbGeAlD
Gefitinib—CSNK1E—Circadian rythm related genes—NPAS2—Creutzfeldt-Jakob disease	0.00323	0.035	CbGpPWpGaD
Gefitinib—ABCB1—lymphoid tissue—Creutzfeldt-Jakob disease	0.00323	0.00355	CbGeAlD
Gefitinib—CYP2D6—cerebellum—Creutzfeldt-Jakob disease	0.00322	0.00355	CbGeAlD
Gefitinib—ERBB3—a6b1 and a6b4 Integrin signaling—YWHAZ—Creutzfeldt-Jakob disease	0.00311	0.0337	CbGpPWpGaD
Gefitinib—ABCB1—spinal cord—Creutzfeldt-Jakob disease	0.00292	0.00322	CbGeAlD
Gefitinib—CYP2D6—brain—Creutzfeldt-Jakob disease	0.00262	0.00289	CbGeAlD
Gefitinib—CHEK2—Cell Cycle—YWHAZ—Creutzfeldt-Jakob disease	0.00248	0.0268	CbGpPWpGaD
Gefitinib—ABCB1—central nervous system—Creutzfeldt-Jakob disease	0.00237	0.00261	CbGeAlD
Gefitinib—ABCB1—cerebellum—Creutzfeldt-Jakob disease	0.00232	0.00256	CbGeAlD
Gefitinib—IRAK4—Signaling by Interleukins—YWHAZ—Creutzfeldt-Jakob disease	0.00194	0.021	CbGpPWpGaD
Gefitinib—EPHA6—Axon guidance—PRNP—Creutzfeldt-Jakob disease	0.00192	0.0207	CbGpPWpGaD
Gefitinib—ABCB1—brain—Creutzfeldt-Jakob disease	0.00188	0.00208	CbGeAlD
Gefitinib—EGFR—a6b1 and a6b4 Integrin signaling—YWHAZ—Creutzfeldt-Jakob disease	0.00173	0.0187	CbGpPWpGaD
Gefitinib—MAP2K5—ErbB1 downstream signaling—YWHAZ—Creutzfeldt-Jakob disease	0.00164	0.0177	CbGpPWpGaD
Gefitinib—CYP1A1—PPARA activates gene expression—NPAS2—Creutzfeldt-Jakob disease	0.0014	0.0152	CbGpPWpGaD
Gefitinib—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—NPAS2—Creutzfeldt-Jakob disease	0.00137	0.0149	CbGpPWpGaD
Gefitinib—EPHA6—Developmental Biology—PRNP—Creutzfeldt-Jakob disease	0.00137	0.0148	CbGpPWpGaD
Gefitinib—IRAK1—Signaling by Interleukins—YWHAZ—Creutzfeldt-Jakob disease	0.00129	0.0139	CbGpPWpGaD
Gefitinib—CSNK1E—TCF dependent signaling in response to WNT—YWHAZ—Creutzfeldt-Jakob disease	0.00116	0.0125	CbGpPWpGaD
Gefitinib—CSNK1E—RNF mutants show enhanced WNT signaling and proliferation—YWHAZ—Creutzfeldt-Jakob disease	0.00112	0.0121	CbGpPWpGaD
Gefitinib—EGFR—Direct p53 effectors—CTSD—Creutzfeldt-Jakob disease	0.0011	0.0119	CbGpPWpGaD
Gefitinib—CSNK1E—Signaling by WNT in cancer—YWHAZ—Creutzfeldt-Jakob disease	0.00104	0.0112	CbGpPWpGaD
Gefitinib—IRAK4—Cytokine Signaling in Immune system—HLA-DQB1—Creutzfeldt-Jakob disease	0.00102	0.011	CbGpPWpGaD
Gefitinib—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—NPAS2—Creutzfeldt-Jakob disease	0.000947	0.0102	CbGpPWpGaD
Gefitinib—IRAK4—Cytokine Signaling in Immune system—YWHAZ—Creutzfeldt-Jakob disease	0.000904	0.00978	CbGpPWpGaD
Gefitinib—EGFR—ErbB1 downstream signaling—YWHAZ—Creutzfeldt-Jakob disease	0.000879	0.00951	CbGpPWpGaD
Gefitinib—CSNK1E—Signaling by Wnt—YWHAZ—Creutzfeldt-Jakob disease	0.000857	0.00926	CbGpPWpGaD
Gefitinib—EGFR—Axon guidance—PRNP—Creutzfeldt-Jakob disease	0.000685	0.00741	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism of lipids and lipoproteins—MTMR7—Creutzfeldt-Jakob disease	0.000682	0.00738	CbGpPWpGaD
Gefitinib—IRAK1—Cytokine Signaling in Immune system—HLA-DQB1—Creutzfeldt-Jakob disease	0.000676	0.00731	CbGpPWpGaD
Gefitinib—ABCB1—Allograft Rejection—HLA-DQB1—Creutzfeldt-Jakob disease	0.000628	0.00679	CbGpPWpGaD
Gefitinib—ALB—Metabolism of lipids and lipoproteins—MTMR7—Creutzfeldt-Jakob disease	0.000622	0.00672	CbGpPWpGaD
Gefitinib—ERBB3—Adaptive Immune System—CTSD—Creutzfeldt-Jakob disease	0.000614	0.00664	CbGpPWpGaD
Gefitinib—IRAK1—Cytokine Signaling in Immune system—YWHAZ—Creutzfeldt-Jakob disease	0.0006	0.00649	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism of lipids and lipoproteins—MTMR7—Creutzfeldt-Jakob disease	0.000558	0.00604	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism of lipids and lipoproteins—MTMR7—Creutzfeldt-Jakob disease	0.000509	0.0055	CbGpPWpGaD
Gefitinib—EGFR—Developmental Biology—PRNP—Creutzfeldt-Jakob disease	0.000489	0.00529	CbGpPWpGaD
Gefitinib—IRAK4—Immune System—CTSD—Creutzfeldt-Jakob disease	0.000467	0.00505	CbGpPWpGaD
Gefitinib—ABCG2—Metabolism—MTMR7—Creutzfeldt-Jakob disease	0.000449	0.00485	CbGpPWpGaD
Gefitinib—ERBB3—Adaptive Immune System—HLA-DQB1—Creutzfeldt-Jakob disease	0.000437	0.00473	CbGpPWpGaD
Gefitinib—ERBB3—Adaptive Immune System—YWHAZ—Creutzfeldt-Jakob disease	0.000388	0.0042	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism of lipids and lipoproteins—NPAS2—Creutzfeldt-Jakob disease	0.000377	0.00408	CbGpPWpGaD
Gefitinib—ERBB3—Immune System—CTSD—Creutzfeldt-Jakob disease	0.000372	0.00402	CbGpPWpGaD
Gefitinib—MKNK1—Disease—YWHAZ—Creutzfeldt-Jakob disease	0.000367	0.00397	CbGpPWpGaD
Gefitinib—ALB—Metabolism of lipids and lipoproteins—NPAS2—Creutzfeldt-Jakob disease	0.000344	0.00372	CbGpPWpGaD
Gefitinib—EGFR—Adaptive Immune System—CTSD—Creutzfeldt-Jakob disease	0.000342	0.00369	CbGpPWpGaD
Gefitinib—IRAK4—Immune System—HLA-DQB1—Creutzfeldt-Jakob disease	0.000333	0.0036	CbGpPWpGaD
Gefitinib—CYP3A5—Metabolism—MTMR7—Creutzfeldt-Jakob disease	0.000322	0.00348	CbGpPWpGaD
Gefitinib—IRAK1—Immune System—CTSD—Creutzfeldt-Jakob disease	0.00031	0.00335	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism of lipids and lipoproteins—NPAS2—Creutzfeldt-Jakob disease	0.000309	0.00334	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism—MTMR7—Creutzfeldt-Jakob disease	0.000304	0.00329	CbGpPWpGaD
Gefitinib—IRAK4—Immune System—YWHAZ—Creutzfeldt-Jakob disease	0.000295	0.00319	CbGpPWpGaD
Gefitinib—CSNK1E—Disease—YWHAZ—Creutzfeldt-Jakob disease	0.000285	0.00309	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism of lipids and lipoproteins—NPAS2—Creutzfeldt-Jakob disease	0.000281	0.00304	CbGpPWpGaD
Gefitinib—ALB—Platelet activation, signaling and aggregation—YWHAZ—Creutzfeldt-Jakob disease	0.000279	0.00302	CbGpPWpGaD
Gefitinib—ALB—Metabolism—MTMR7—Creutzfeldt-Jakob disease	0.000277	0.00299	CbGpPWpGaD
Gefitinib—ERBB3—Immune System—HLA-DQB1—Creutzfeldt-Jakob disease	0.000265	0.00287	CbGpPWpGaD
Gefitinib—MKNK1—Signaling Pathways—YWHAZ—Creutzfeldt-Jakob disease	0.000257	0.00278	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism—MTMR7—Creutzfeldt-Jakob disease	0.000249	0.00269	CbGpPWpGaD
Gefitinib—ABCG2—Metabolism—NPAS2—Creutzfeldt-Jakob disease	0.000248	0.00268	CbGpPWpGaD
Gefitinib—EGFR—Adaptive Immune System—HLA-DQB1—Creutzfeldt-Jakob disease	0.000243	0.00263	CbGpPWpGaD
Gefitinib—ABCB1—Metabolism—MTMR7—Creutzfeldt-Jakob disease	0.000243	0.00262	CbGpPWpGaD
Gefitinib—ERBB3—Immune System—YWHAZ—Creutzfeldt-Jakob disease	0.000235	0.00255	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—MTMR7—Creutzfeldt-Jakob disease	0.000229	0.00247	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—MTMR7—Creutzfeldt-Jakob disease	0.000227	0.00245	CbGpPWpGaD
Gefitinib—IRAK1—Immune System—HLA-DQB1—Creutzfeldt-Jakob disease	0.000221	0.00239	CbGpPWpGaD
Gefitinib—ERBB3—Disease—YWHAZ—Creutzfeldt-Jakob disease	0.000217	0.00235	CbGpPWpGaD
Gefitinib—EGFR—Adaptive Immune System—YWHAZ—Creutzfeldt-Jakob disease	0.000216	0.00234	CbGpPWpGaD
Gefitinib—EGFR—Immune System—CTSD—Creutzfeldt-Jakob disease	0.000207	0.00224	CbGpPWpGaD
Gefitinib—CSNK1E—Signaling Pathways—YWHAZ—Creutzfeldt-Jakob disease	0.0002	0.00216	CbGpPWpGaD
Gefitinib—IRAK1—Immune System—YWHAZ—Creutzfeldt-Jakob disease	0.000196	0.00212	CbGpPWpGaD
Gefitinib—CYP3A5—Metabolism—NPAS2—Creutzfeldt-Jakob disease	0.000178	0.00192	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism—NPAS2—Creutzfeldt-Jakob disease	0.000168	0.00182	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling Pathways—YWHAZ—Creutzfeldt-Jakob disease	0.000158	0.00171	CbGpPWpGaD
Gefitinib—ALB—Metabolism—NPAS2—Creutzfeldt-Jakob disease	0.000153	0.00166	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—YWHAZ—Creutzfeldt-Jakob disease	0.000152	0.00165	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—MTMR7—Creutzfeldt-Jakob disease	0.000149	0.00162	CbGpPWpGaD
Gefitinib—EGFR—Immune System—HLA-DQB1—Creutzfeldt-Jakob disease	0.000148	0.0016	CbGpPWpGaD
Gefitinib—ALB—Hemostasis—YWHAZ—Creutzfeldt-Jakob disease	0.000144	0.00156	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism—NPAS2—Creutzfeldt-Jakob disease	0.000137	0.00149	CbGpPWpGaD
Gefitinib—ABCB1—Metabolism—NPAS2—Creutzfeldt-Jakob disease	0.000134	0.00145	CbGpPWpGaD
Gefitinib—EGFR—Immune System—YWHAZ—Creutzfeldt-Jakob disease	0.000131	0.00142	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—YWHAZ—Creutzfeldt-Jakob disease	0.000127	0.00137	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—NPAS2—Creutzfeldt-Jakob disease	0.000126	0.00137	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—NPAS2—Creutzfeldt-Jakob disease	0.000125	0.00136	CbGpPWpGaD
Gefitinib—EGFR—Disease—YWHAZ—Creutzfeldt-Jakob disease	0.000121	0.00131	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—YWHAZ—Creutzfeldt-Jakob disease	8.47e-05	0.000916	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—NPAS2—Creutzfeldt-Jakob disease	8.26e-05	0.000894	CbGpPWpGaD
